REporting recommendations for tumour MARKer prognostic studies (REMARK) - Wikidata - wikimedia - TriplyDB

REporting recommendations for tumour MARKer prognostic studies (REMARK)

REporting recommendations for tumour MARKer prognostic studies (REMARK)

http://www.wikidata.org/entity/Q36615178

about

Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting Guidelines for reporting health research: the EQUATOR network's survey of guideline authors Interpretation of microarray data in cancer Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis Cancer biomarkers Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis Prognostic role of survivin in bladder cancer: a systematic review and meta-analysis MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond Prognostic value of microRNA expression in operable non-small cell lung cancer patients Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and β-catenin gene signature predicts survival Invasive breast cancer: stratification of histological grade by gene-based assays: a still relevant example from an older data set Prognosis Research Strategy (PROGRESS) 2: prognostic factor research Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond.Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.A data standard for sourcing fit-for-purpose biological samples in an integrated virtual network of biobanks.Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist.High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression.S100β as a serum marker in endocrine resistant breast cancer.Construction of a pathological risk model of occult lymph node metastases for prognostication by semi-automated image analysis of tumor budding in early-stage oral squamous cell carcinoma.Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer--a prospective study.Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies.Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer Tropomyosin-related receptor kinase B at the invasive front and tumour cell dedifferentiation in gastric cancer Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis.Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients.Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective study Correlation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women.

P2860

Q21245257-BD443500-0FB2-4CCE-B77D-77019730611B Q21563406-7D864B2E-2282-4FCE-8B4E-40587B778AF6 Q24289307-3C3E7687-F3EC-4385-BE6B-FEC6FE8DE6CB Q24597456-0F8DBB20-72B9-439D-AA28-39DA92276955 Q26746258-91FE96C7-232B-40EE-970C-69657D975C83 Q26748691-D42427E2-FAFE-4D31-B8A8-5EDE40EE3D34 Q26864429-159F32F3-0BE4-4CC1-B539-51E3F0325E1A Q27024810-EE4892AA-15A2-43F6-8DBC-8CB7BB5B0659 Q27028122-EB220257-F902-4CCB-9126-277E879D3F78 Q27853354-5657FC19-2DB4-450C-AA74-4A81BDDC0745 Q28085367-900BA9B5-9C06-4BBB-9E9A-9EE3726F579B Q28222847-C3B7A491-33C1-4765-9A9C-9798980E0961 Q28388487-EB57C07E-F31E-48AD-9215-38E225A732F2 Q28396343-2FF17570-1982-429A-9B22-14BBEAF7576C Q28483648-3796F40A-758E-4280-9637-041941837CFE Q28652779-75E549F3-180C-4C7E-B50E-33DBE9868BF7 Q28709212-C057C8B4-9E43-4507-98E0-D3810FCCD69A Q30371634-FD27DA6C-0A14-4DB2-B83F-B642FF497D7B Q30416074-F4877D43-BF8E-43F8-B053-81028CFF4F05 Q30514241-E0BCAE39-538D-4080-B41C-668AD1570D5E Q30812271-D68C6F6A-AF07-4C13-97D4-8DF3A5D16AF3 Q30860218-37448386-2040-46FB-BD17-AE62D4185BA2 Q33514114-8CD3DE65-9D65-4F43-BC4C-D10619F50784 Q33556608-9C5939BC-F7C2-417C-B56E-0ACA978BEB1A Q33566888-1606DAEF-CF90-40D2-AC46-3F86C3E1EB7D Q33638337-E3E741CC-3A3E-443A-9940-E1A84702D017 Q33665833-171468C4-3126-4469-A8E0-2E69A0E1D3FE Q33709284-B979421F-9833-4539-B8B8-3CD5B787B2D2 Q33725671-83DA662A-A96C-4019-98E9-7D9FD5ACC46B Q33750119-F73BAB94-C1AF-4A9F-BD76-06493B8F3A59 Q33750123-FF9DA5E2-4D96-46E6-B57A-6C9FF64470BD Q33750128-08DDA5A1-DAEB-4930-B6A3-B8C30A28C431 Q33788235-FA4A150E-760E-424A-8EE1-098FC0277C63 Q33821114-C1EE4A52-1CD0-406B-8988-DD689BCE9739 Q33829495-5EC0E1A1-2C7B-4080-850B-819B37B7CBD0 Q33958974-085636DE-9E62-4C89-8FF7-DF99C6459AD7 Q34105741-CCB37F73-130D-461E-9564-5ED8BB8F4E11 Q34107754-FA7E34FE-A199-44E8-914B-949FE4C9DBC1 Q34113564-3D688093-B1E1-4C6D-9072-D69FF6D03349 Q34155703-5FD5654F-FF34-41F4-BA44-FAEF7274D70B

P2860

REporting recommendations for tumour MARKer prognostic studies (REMARK)

http://www.wikidata.org/entity/Q36615178

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

REporting recommendations for tumour MARKer prognostic studies (REMARK)

@ast

REporting recommendations for tumour MARKer prognostic studies (REMARK)

@en

type

label

REporting recommendations for tumour MARKer prognostic studies (REMARK)

@ast

REporting recommendations for tumour MARKer prognostic studies (REMARK)

@en

prefLabel

REporting recommendations for tumour MARKer prognostic studies (REMARK)

@ast

REporting recommendations for tumour MARKer prognostic studies (REMARK)

@en

P1433

Q36615178-079D2FF6-7F25-4E34-B9CF-E968711ADE99

P1476

Q36615178-D6FFEFAE-A6C6-40DA-9048-1546A3C01C3C

P2093

Q36615178-046A1D3A-65A7-450C-89C6-C66944602E92

Q36615178-0FD0465D-401E-4E49-90FB-C35CE54D3CB6

Q36615178-227F7328-CDC6-4620-A6F1-8BB10A9AD837

Q36615178-83A9CC72-6500-4CC1-8C32-6D5B2E1F8FFD

Q36615178-8DB7525D-1196-43FE-B57B-C4B449BE5B90

Q36615178-A9320AF4-3CCA-4A45-A1A4-63E7B18AC90A

Q36615178-B9381880-AB9F-4BE4-9C8C-98C33577BD19

P2860

Q36615178-1808800B-177F-4F68-9405-43F92B5F6F23

Q36615178-2479FB51-2525-4386-B146-0448D62E968E

Q36615178-291A80C8-5380-4D85-9493-9D8C930C76A9

Q36615178-2C06D2CB-E518-476D-ACCE-260332F2DEC7

Q36615178-30884850-84DC-4E3A-A509-682D3CC41C50

Q36615178-3E36F2D1-177C-4649-8853-6FC74B3F8499

Q36615178-3F00BC7A-ACCD-4E39-AF88-E62361EAAE84

Q36615178-3FCA5AAC-E818-48F1-8730-D91C724992CF

Q36615178-48C82A1A-A633-48E6-AF9D-32CA3E5FF803

Q36615178-57FCC49D-795A-47EF-A9F8-919C169B4957

P2888

Q36615178-629CF33E-6D55-49B9-B6CC-13A2CC4247FD

P304

Q36615178-2CF91378-549C-4A40-8800-0C4332E65CC6

P31

Q36615178-D4494DD3-2DCB-44F7-9EEE-B25394F98268

P356

Q36615178-CF2ECA53-78E1-46CB-8BA5-F096A763D86F

P407

Q36615178-380EA778-AAE2-4418-83B5-85FA4CDBC9EB

P433

Q36615178-24B7E6D2-A3F3-4102-8EB8-922B50BF112F

P478

Q36615178-B6456660-A1EA-47EF-A3A5-2A9D65F60589

P577

Q36615178-E35BDEE4-5084-4B89-9497-75B7367A9F11

P6179

Q36615178-77668420-52CC-4A6C-9439-961C05DE4EF4

P698

Q36615178-676890A3-1466-49A4-89B5-6BD694BA3F5E

P932

Q36615178-8585C482-186E-412F-9D6C-0855DB03C1AF

P356

P1433

British Journal of Cancer

P1476

REporting recommendations for tumour MARKer prognostic studies (REMARK)

@en

P2093

D G Altman

http://www.w3.org/2001/XMLSchema#string

G M Clark

http://www.w3.org/2001/XMLSchema#string

L M McShane

http://www.w3.org/2001/XMLSchema#string

M Gion

http://www.w3.org/2001/XMLSchema#string

S E Taube

http://www.w3.org/2001/XMLSchema#string

Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics

http://www.w3.org/2001/XMLSchema#string

W Sauerbrei

http://www.w3.org/2001/XMLSchema#string

P2860

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

Potential for selection bias with tumor tissue retrieval in molecular epidemiology studies.

Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines

Methodological challenges in the evaluation of prognostic factors in breast cancer.

Predicting the future: a critical appraisal of cancer prognosis studies.

Systematic reviews of evaluations of prognostic variables.

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

P2888

P304

387-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602678

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1028545719

http://www.w3.org/2001/XMLSchema#string

P698

16106245

http://www.w3.org/2001/XMLSchema#string

P932

2361579

http://www.w3.org/2001/XMLSchema#string